The validation of measurement of cerebral blood volume (CBV) and cerebral blood flow (CBF) using near infrared spectroscopy (NIRS) against jugular venous occlusion plethysmography is described. Repeated measurements in six infants were made using both techniques simultaneously. A close relationship between the two measurements of change in CBV was obtained in five infants. There was also a close relationship for measurement of CBF in four infants. This study confirms the possibility of using NIRS to monitor CBV continuously in the premature infant. This parameter may prove to be of greater clinical value than the intermittent measurement of CBF.
Near infrared spectroscopy (NIRS) is a new technique originally proposed by Jobsis in 1977
for continuous monitoring of cerebral haemoglobin concentration and oxygenation. ' The NIRS instrumentation developed in this department has been used to study these cerebral parameters continuously by transillumination of the neonatal head. Algorithms are used to convert the changes in absorbance at individual wavelengths to changes in the concentration of oxygenated, deoxygenated, and total haemoglobin.2 Assuming a constant packed cell volume, a changed in total haemoglobin implies a change in cerebral blood volume (CBV). Clinical studies using this technique have demonstrated that, whereas mild hypoxaemia leads to an increase in CBV, bradycardia causes a rapid fall with a small overshoot on recovery. 3 Changes in CBV attributable to alterations in carbon dioxide tension have also been documented. 4 5 Although the magnitude of these changes can be calculated from theoretical considerations, the technique for measurement of CBV has never been validated by an independent technique.
Strain gauge plethysmography has been used to calculate cerebral blood flow (CBF) from a consideration of change in cerebral volume in relation to time. 6 Although the technique has been criticised for this purpose, it is generally accepted that an accurate measurement of increase in head circumference resulting from jugular venous occlusion does provide a useful method of quantifying volume change.
Methods

INSTRUMENTATION
NIRS
This technique uses near infrared light emitted by three semiconductor laser diodes to transilluminate the neonatal head.79 The near infrared light from the semiconductor diodes is coupled to an optical fibre, which is attached to the head. The light emerging after absorption is collected by a similar optical fibre bundle, detected by an avalanche photodiode and amplified. After initial calibration, the overall absorbance at each of the three wavelengths (775 nm, 845 nm, and 904 nm) can be determined. The principle behind the technique is that the absorbance at these wavelengths is sensitive to the concentrations of oxygenated and deoxygenated haemoglobin in the brain.
For the analysis a modified form of LambertBeer law is assumed to hold for biological tissue. In its simplest form this may be expressed as: A=eCnL+B where, A is the optical absorption (optical density units) of the chromophore of concentration C (mmol/l) having an absorption coefficient e (l/cmxmmol) and a physical path length L (cm); and B is a term to account for the losses in absorption due to the skin-probe interface and scattering. The optical path length is expressed as nL where n is a path length multiplication factor used to take into account the increase in optical pathlength due to scattering, and we have used a factor of 4-3.4 Thus change in absorbance can be related to change in concentration as: AA= AC(enL) provided the assumption is made that scattering and losses at the skin-fibre interface remains unchanged during the study period.
Thus if AA775, AA845, and AA904 are the changes in absorbances at these wavelengths then change in total haemoglobin (HbT) is given by:
where L is the direct spacing between the optical probes.
NIRS cannot be used continuously to monitor absolute CBV, but can be used to monitor changes in the total haemoglobin in the neonatal brain. The change in total haemoglobin is normally given as mmol/l but can be converted to blood volume if the packed cell volume is known, and assuming a cerebral to large vessel packed cell volume ratio of 07. 4 The molecular weight of haemoglobin is taken to be 64 500. Thus the change in CBV may be expressed as ml/100 ml. The CBF can be calculated from the rate of change of blood volume as monitored by NIRS, and expressed as ml/100 ml/min. Strain gauge plethysmography Strain gauge plethysmography employs a Wheatstone bridge to determine the changes in length of the gauge.'0 1 l This technique can be adapted to determine CBF.'2 13 For neonatal cerebral studies the strain gauge consists of a silicone rubber tube of internal diameter 1 mm and length 50 cm which is filled with mercury. The tube is doubled on itself to form a four stranded gauge. Copper pins are attached to the ends for electrical connections, and connected to one arm of the bridge circuit.
The electronic circuit produces a voltage change which is proportional to the change in occipitofrontal head circumference of the baby, when the jugular veins are occluded. The near infrared data and strain gauge information can be displayed and stored simultaneously.
The technique relies on the compliance of the neonatal skull due to the softness of the bones and lack of fusion of the sutures. It is assumed that any change in CBV causes the entire head to expand or contract isotropically. The change in head circumference when the overall length of the gauge is changed by 1 mm can be determined in situ with the calibration device. Provided the head circumference is known, the change in CBV as a result of jugular venous occlusion can be calculated as given below. The rate of change of CBV can also be calculated to give a measure of apparent CBF. This acknowledges the assumptions inherent in the technique, which tend to lead to an underestimate of flow. 6 Cooke et al have reported that the relationship between brain weight and occipitofrontal head circumference is cubic in nature12:
Brain weight=C3001 x0-009 PATIENTS AND PROCEDURES Six premature infants were studied. These were all infants who had had no major neonatal problems and had normal cranial ultrasound scans at the time of the study. Gestation ranged from 31 to 33 weeks (median 32 weeks) and birth weight from 1540 to 2010 g (median 1735 g). Age at the time of study was from 3 to 16 days, median 15 days.
The infants were studied after a feed, while at rest or in quiet sleep. The head circumference was measured, the strain gauge was then placed around the occipitofrontal circumference and fastened using Velcro tape. The NIRS probes were held in place a measured distance apart using double sided adhesive rings and elastic webbing. Great care was needed to ensure that that strapping for the NIRS probes did not touch or interfere with the strain gauge. The baby was then positioned on the lap of one investigator with the head supported by a roll of cloth. The connecting wires and the NIRS optical fibres were supported to prevent any tension.
With the equipment in position and the infant at rest, small pulsations were obtained on the strain gauge trace, due to the cardiac cycle ( fig 1) . These were not seen on the NIRS traces because of the two second averaging time used. Occlusions were performed as follows: the two jugular veins in the lower third of the neck were occluded simultaneously using the index fingers for a period of five seconds, then released. Once the trace had returned to baseline, the occlusion was repeated, to approximately 10 occlusions. A calibration manoeuvre was then performed. In some infants it was not possible to analyse 10 '5 The mean apparent CBF measured by strain gauge was 9-73 ml/100 ml/min, while the mean CBF calculated from the NIR data was 9 05 ml/100 ml/min.
Using the same statistical analysis as the CBV the calculated test statistics for CBF was 0-01, which again demonstrates that any deviation from agreement between the two methods is not significant.
Discussion
Disturbance to cerebral blood flow is likely to be an important factor in the aetiology of neonatal cerebral injury. Therefore a number of different methods have been developed for the assessment of CBF in premature infants.
The problems inherent in the technique of jugular venous occlusion plethysmography for the measurement of CBF have been described. ' The validity of the estimation of CBF depends upon assumptions that cerebrospinal fluid is not displaced and only a small volume of blood escapes through the vertebral veins during an occlusion. The skull is assumed to be perfectly compliant. Otherlimitations include the practical difficulties of positioning the infant correctly and effecting a good clean occlusion. A rise in venous pressure is a necessary consequence of the technique and although this is well tolerated by healthy infants, it may be hazardous in sick infants who may already be hypoxic or hypotensive or have raised intracranial pressure. Concern has also been expressed over the use of mercury which certainly should not be used in an enclosed space such as an incubator. The change in occipitofrontal circumference after jugular venous occlusion lasting about six seconds is taken to be 1 mm in this exampleassuming the skull to be perfectly compliant. The change in diameter for this circumferential change is from 95-45 to 95-77 mm. The optical probes for studies on neonates undergoing jugular venous occlusion are taken to be about 5 cm apart for this calculation. If it is assumed that the angle subtended is 60°, the change in physical path length is from 47-72 to 47-88 mm. This artifactual change is additive and will be reflected in the calculated haemoglobin concentration and hence will result in an overestimation of change in CBV up to 25% on babies with fully compliant skull. This error will be less on babies that have a less compliant skull. Measurement of cerebral blood flow using NIRS gave comparable results to the strain gauge measurements, However, the limitations of using jugular venous occlusion remain. All methods of measuring CBF involve some form of intervention. A technique described by Wyatt et al using a small change in arterial oxygen saturation in conjunction with NIRS certainly causes less disturbance to the infant,4 but the fact that a change is necessary means that CBF cannot be continuously monitored.
We have shown that CBV can be monitored non-invasively and continuously using NIRS. Studies using this technique have shown that measure of CBV is sensitive to changes that are known to cause changes in flow. These include bradycardia, hypoxaemia, and changes in carbon dioxide tension.3
If our understanding of the aetiology of cerebral ischaemic lesions occurring during intensive care is to be increased then a continuous measurement is essential. A continuous measurement of CBV may prove to be of greater value than intermittent measurements of flow. 
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